Perscription drugs spilling out of their container, on toap of one hundred dollar bills.

Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector General found.

At the same time, Part D spending for Ozempic increased from $552 million to $9.2 billion and the number of Part D enrollees filling a prescription for Ozempic increased from 142,479 to 1,465,482 (a 929% increase).

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Broker Regulation
Consumer Driven Health Care
Core and Group Health
Health Care Reform